Christina Piperi
Christina Piperi is an expert in Biochemistry at National and Kapodistrian University of Athens (Greece). As of October 2026, ScienceLeadR ranks Christina Piperi in the top 1% of experts worldwide for Glioma. Christina Piperi has authored 311 publications, the most recent in 2026. SLR score: 980 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Oncology - Immunology - Hematology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 311
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The TET Protein Family in Gliomas: Epigenetic Regulation, Molecular Pathogenesis, and Therapeutic Opportunities. PMID 42942258 — brain neoplasms, genes, glioma, protein isoforms, neoplasms, chromatin, therapeutics | Life (Basel) | 2026 | 0 |
| Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy. PMID 42697339 — cells, glioma, neoplasms, antigen presentation, immunotherapy, therapeutics | Biochim Biophys Acta Rev Cancer | 2026 | 0 |
| Epigenetic drift and LINE-1 activation in aging brain: Implications for neurodegenerative disease. PMID 42580558 — cells, growth, biochemistry, aging, brain, genome, neurodegenerative diseases | Mech Ageing Dev | 2026 | 0 |
| Anti-inflammatory mechanisms of breast milk exosomes in neonatal immune development. PMID 42686003 — milk, human, physiology, milk, biochemistry, exosomes, pharmacology, breast | Life Sci | 2026 | 0 |
| Targeting SUV4-20H2-mediated H4K20 methylation restrains growth and migration in pediatric high-grade astrocytomas. PMID 42659832 — cells, catenins, glioma, growth, astrocytoma, stress, physiological, neoplasms, chromatin, cadherins, cell line, therapeutics, apoptosis, tissues | Neurotherapeutics | 2026 | 0 |
LeadR Networks
Main global connection map